ConductScience.org, home

Paper40178377

Granulosa cell death is a significant contributor to DNA-damaging chemotherapy-induced ovarian insufficiency†.

Kawano M and 3 others. Biol Reprod, 2025. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. Granulosa cell death is a significant contributor to DNA-damaging chemotherapy-induced ovarian insufficiency†. Papers, record 40178377. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40178377

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Granulosa cell death is a significant contributor to DNA-damaging chemotherapy-induced ovarian insufficiency†.
PubMed
Journal
Biol Reprod
PubMed
Year
2025
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
2.5, provisional
iCite
Revised in PubMed
2026-08-13
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kawano MMahiru
2McKey JJennifer
3Batchvarov ISIordan S
4Capel BBlanche

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Granulosa CellsMajor topic
Primary Ovarian InsufficiencyMajor topic
CyclophosphamideMajor topic
BusulfanMajor topic
DNA DamageMajor topic
Antineoplastic Agents, AlkylatingMajor topic
Animals
Female
Mice
Apoptosis
Ovarian Follicle
Cell Death

Source PubMed

Download CSV of topics

Grants8

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 HD090050NICHD NIH HHSUnited StatesR01HD090050PubMed and NIHNIH RePORTER
Uehara Memorial Foundation and Kanzawa Medical Research FoundationPubMedPubMed
130426-PF-17-209-01-TBGAmerican Cancer SocietyPubMedPubMed
#SAE20151203560Fondation ARC pour la Recherche contre le CancerPubMedPubMed
#130426-PF-17-209-01-TBGAmerican Cancer SocietyPubMedPubMed
The Uehara Memorial Foundation and Kanzawa Medical Research FoundationPubMedPubMed
1R01HD090050-0NIH HHSUnited StatesR01HD090050PubMed and NIHNIH RePORTER
SAE20151203560Fondation ARC pour la Recherche contre le CancerPubMedPubMed

Download CSV of grants

References34

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116055554Essential role of BAX,BAK in B cell homeostasis and prevention of autoimmune disease.Proc Natl Acad Sci U S A2005https://conductscience.org/library/papers/16055554PubMed
230530902Inhibitors of apoptosis protect the ovarian reserve from cyclophosphamide.J Endocrinol2019https://conductscience.org/library/papers/30530902PubMed
323677591Cyclophosphamide triggers follicle activation and "burnout"; AS101 prevents follicle loss and preserves fertility.Sci Transl Med2013https://conductscience.org/library/papers/23677591PubMed
426674557Fertility preservation in pre-pubertal girls with cancer: the role of ovarian tissue cryopreservation.Fertil Steril2016https://conductscience.org/library/papers/26674557PubMed
536084276Busulfan Plus Cyclophosphamide Versus Total Body Irradiation Plus Cyclophosphamide for Adults Acute B Lymphoblastic Leukemia: An Open-Label, Multicenter, Phase III Trial.J Clin Oncol2023https://conductscience.org/library/papers/36084276PubMed
636888938Cancer Treatment-Related Ovarian Dysfunction in Women of Childbearing Potential: Management and Fertility Preservation Options.J Clin Oncol2023https://conductscience.org/library/papers/36888938PubMed
733619021The Adolescent and Young Adult (AYA) Horizon Study: An AYA Cancer Survivorship Cohort.Cancer Epidemiol Biomarkers Prev2021https://conductscience.org/library/papers/33619021PubMed
827458300
Recommendations for Premature Ovarian Insufficiency Surveillance for Female Survivors of Childhood, Adolescent, and Young Adult Cancer: A Report From the International Late Effects of Childhood Cancer Guideline Harmonization Group in Collaboration With the PanCareSurFup Consortium.
J Clin Oncol2016https://conductscience.org/library/papers/27458300PubMed
937862420CHEK2 signaling is the key regulator of oocyte survival after chemotherapy.Sci Adv2023https://conductscience.org/library/papers/37862420PubMed
1029795269Loss of PUMA protects the ovarian reserve during DNA-damaging chemotherapy and preserves fertility.Cell Death Dis2018https://conductscience.org/library/papers/29795269PubMed
1131600388Ovarian damage from chemotherapy and current approaches to its protection.Hum Reprod Update2019https://conductscience.org/library/papers/31600388PubMed
1336857094Beyond apoptosis: evidence of other regulated cell death pathways in the ovary throughout development and life.Hum Reprod Update2023https://conductscience.org/library/papers/36857094PubMed
1422137491Impact of cancer therapies on ovarian reserve.Fertil Steril2012https://conductscience.org/library/papers/22137491PubMed
1537797647Measuring ovarian toxicity in clinical trials: an American Society of Clinical Oncology research statement.Lancet Oncol2023https://conductscience.org/library/papers/37797647PubMed
1620023653A robust and high-throughput Cre reporting and characterization system for the whole mouse brain.Nat Neurosci2010https://conductscience.org/library/papers/20023653PubMed
1731717833The Impact of Chemotherapy on the Ovaries: Molecular Aspects and the Prevention of Ovarian Damage.Int J Mol Sci2019https://conductscience.org/library/papers/31717833PubMed
1837068157The future of fertility preservation for women treated with chemotherapy.Reprod Fertil2023https://conductscience.org/library/papers/37068157PubMed
1921994953Resumption of ovarian function and pregnancies in 358 patients with premature ovarian failure.J Clin Endocrinol Metab2011https://conductscience.org/library/papers/21994953PubMed
2017135639Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer.J Clin Oncol2006https://conductscience.org/library/papers/17135639PubMed
2120715176A mouse tool for conditional mutagenesis in ovarian granulosa cells.Genesis2010https://conductscience.org/library/papers/20715176PubMed

See all 34 referencesDownload CSV of references

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
42935693Evaluation of inflammatory status and macrophage polarization in premature ovarian insufficiency mice induced by chemotherapy.Front Endocrinol (Lausanne)2026https://conductscience.org/library/papers/42935693PubMed
42852174Potential Ameliorative Effect of Zosima absinthifolia on Diminished Ovarian Reserve in Rats.Iran J Pharm Res2026https://conductscience.org/library/papers/42852174PubMed
42851348Integrated network toxicology and multi-omics profiling reveal cell cycle, DNA damage repair, and metabolic alterations in cyclophosphamide-induced premature ovarian insufficiency.Front Pharmacol2026https://conductscience.org/library/papers/42851348PubMed
42757484Therapeutic effects of exosome‑based hyperin delivery in a cyclophosphamide‑induced mouse model of diminished ovarian reserve.Mol Med Rep2026https://conductscience.org/library/papers/42757484PubMed
42477697Cyclophosphamide-induced animal models of ovarian dysfunction: from molecular mechanisms and modeling strategies to validation criteria.J Ovarian Res2026https://conductscience.org/library/papers/42477697PubMed
42351968Urolithin A-Enhanced Multi-Bioactive Formulation Mitigates Cyclophosphamide-Induced Premature Ovarian Failure Through Suppression of Oxidative-Inflammatory Stress and Preservation of Follicle Fate.Antioxidants (Basel)2026https://conductscience.org/library/papers/42351968PubMed
41989521Relationship between different modes of death and premature ovarian insufficiency: a literature review.Apoptosis2026https://conductscience.org/library/papers/41989521PubMed
41898522A Defined Patho-Mechanism for Acute Radiation Syndrome Death and a Three-Drug Regimen to Prevent It.Int J Mol Sci2026https://conductscience.org/library/papers/41898522PubMed
41652498ANGPTL4 induces granulosa cells proliferation dysfunction in PCOS by regulating the immune microenvironment and WNT signaling pathway.J Ovarian Res2026https://conductscience.org/library/papers/41652498PubMed
41160728Establishment of an optimized chemotherapy-induced mouse model for premature ovarian failure: protocol and findings.Aging (Albany NY)2025https://conductscience.org/library/papers/41160728PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40178377

GET https://conductscience.org/api/papers/v1/40178377/references?page=2